Literature DB >> 2213722

The effect of adjuvants on antibody titers in mouse vaginal fluid after intravaginal immunization.

M A Thapar1, E L Parr, M B Parr.   

Abstract

Intravaginal (ivag) immunization elicits secretory immune responses in the female reproductive tract, but little is known about the safety and effectiveness of adjuvants for such immunization. Mice were immunized intravaginally once daily for 5 days with large doses of horse ferritin combined with aluminum hydroxide (AH), muramyl dipeptide (MDP), monophosphoryl lipid A (MPL), dimethyl dioctadecyl ammonium bromide (DDA) or cholera toxin (CT). Titers of anti-ferritin IgA and IgG were measured in vaginal fluid by ELISA. The most effective adjuvant for ivag primary immunization was AH, while MPL was most effective for ivag boosting. None of the adjuvants caused a detectable tissue reaction in vaginal mucosa. Primary ivag immunization for 5 days with ferritin and AH followed by ivag boosting for 5 days with ferritin and MPL elicited higher IgA titers in vaginal fluid than systemic priming and boosting with ferritin and AH or systemic priming and ivag boosting with ferritin and MPL. Systemically immunized animals exhibited the highest IgG titers in vaginal fluid. The data indicate that adjuvants, particularly AH, can increase local immune responses to intravaginal immunization, but it should be noted that multiple applications of large doses of antigen were used and that this route of sensitization may be relatively inefficient.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213722     DOI: 10.1016/0165-0378(90)90003-o

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  7 in total

Review 1.  Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system.

Authors:  H Y Wu; M W Russell
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

2.  Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria.

Authors:  Corinne Grangette; Heide Müller-Alouf; Pascal Hols; Denise Goudercourt; Jean Delcour; Mireille Turneer; Annick Mercenier
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.

Authors:  A C Menge; S M Michalek; M W Russell; J Mestecky
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer.

Authors:  Hakim Echchannaoui; Matteo Bianchi; David Baud; Martine Bobst; Jean-Christophe Stehle; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

5.  Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges.

Authors:  Zandrea Ambrose; Lara Compton; Michael Piatak; Ding Lu; W Gregory Alvord; Mariusz S Lubomirski; James E K Hildreth; Jeffrey D Lifson; Christopher J Miller; Vineet N KewalRamani
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

6.  Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women.

Authors:  K Hordnes; T Tynning; A I Kvam; R Jonsson; B Haneberg
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

7.  Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.

Authors:  A Di Tommaso; G Saletti; M Pizza; R Rappuoli; G Dougan; S Abrignani; G Douce; M T De Magistris
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.